The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(3S,4R)-N-(3,4-dichlorophenyl)-4-(isobutylamino)tetrahydrothiophene-3-carboxamide 1,1-dioxide ID: ALA5279756
Max Phase: Preclinical
Molecular Formula: C15H20Cl2N2O3S
Molecular Weight: 379.31
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)CN[C@H]1CS(=O)(=O)C[C@@H]1C(=O)Nc1ccc(Cl)c(Cl)c1
Standard InChI: InChI=1S/C15H20Cl2N2O3S/c1-9(2)6-18-14-8-23(21,22)7-11(14)15(20)19-10-3-4-12(16)13(17)5-10/h3-5,9,11,14,18H,6-8H2,1-2H3,(H,19,20)/t11-,14-/m0/s1
Standard InChI Key: MQTRJKDNSMFBSW-FZMZJTMJSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
-1.0310 0.3580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2060 0.3580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0441 -0.4459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6094 -0.9167 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.2769 -0.4247 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4434 1.0723 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.2682 1.0723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6806 0.3580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.5054 0.3580 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2682 -0.3563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2063 1.0723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0310 1.0723 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4453 0.3549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0225 -1.6323 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.1978 -1.6323 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.2060 1.7866 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.2702 0.3546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6806 -0.3578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2681 -1.0723 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4474 -1.0739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0310 -0.3623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6805 -1.7866 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.5054 -0.3578 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
1 5 1 0
5 4 1 0
1 6 1 6
6 7 1 0
7 8 1 0
8 9 1 0
8 10 1 0
2 11 1 1
11 12 1 0
12 13 1 0
4 14 2 0
4 15 2 0
11 16 2 0
17 13 2 0
18 17 1 0
19 18 2 0
20 19 1 0
21 20 2 0
13 21 1 0
19 22 1 0
18 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.31Molecular Weight (Monoisotopic): 378.0572AlogP: 2.59#Rotatable Bonds: 5Polar Surface Area: 75.27Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.60CX Basic pKa: 8.50CX LogP: 2.08CX LogD: 0.96Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.82Np Likeness Score: -1.51
References 1. Jo J, Kim J, Ibrahim L, Kumar M, Iaconelli J, Tran CS, Moon HR, Jung Y, Wiseman RL, Lairson LL, Chatterjee AK, Bollong MJ, Yun H.. (2023) Optimization of 3-aminotetrahydrothiophene 1,1-dioxides with improved potency and efficacy as non-electrophilic antioxidant response element (ARE) activators., 89 [PMID:37116763 ] [10.1016/j.bmcl.2023.129306 ]